Janus Henderson Biotech Innovation Master Fund Ltd - Insider Non-Derivative Transactions at ARCA biopharma, Inc. (ABIO) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Aug 16, 2024, Janus Henderson Biotech Innovation Master Fund Ltd's relationship to ARCA biopharma, Inc. (ABIO) is TenPercentOwner, and currently has 2,117,213 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ABIO insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Janus Henderson Biotech Innovation Master Fund Ltd - Insider Non-Derivative Transactions of ABIO Common Stock

Janus Henderson Biotech Innovation Master Fund Ltd - Insider Non-Derivative Transactions at ABIO

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Aug 17, 2024	P -- (Common Stock)	5390	2.93	2116785
Aug 17, 2024	P -- (Common Stock)	428	2.98	2117213
Jul 12, 2024	P -- (Common Stock)	94537	3.45	1891312
Jul 11, 2024	P -- (Common Stock)	33500	3.46	1774812
Jul 11, 2024	P -- (Common Stock)	21963	3.46	1796775
Jul 10, 2024	P -- (Common Stock)	16917	3.43	1741312
Jul 9, 2024	P -- (Common Stock)	29892	3.41	1706795
Jul 9, 2024	P -- (Common Stock)	17600	3.54	1724395
Jul 6, 2024	P -- (Common Stock)	23326	3.43	1671903
Jul 6, 2024	P -- (Common Stock)	5000	3.41	1676903
Jul 4, 2024	P -- (Common Stock)	166042	3.55	1648577